BiyaPay Analyst: Surged 600x in Six Months! Is the 'MM Coin' in the Stock Market an Opportunity or a Bubble?

BlockBeats News, July 16th, BiyaPay analyst stated that RegenChain (RGC), a Nasdaq-listed company, has seen its stock price surge 642 times in the past six months, earning it the title of the "NASDAQ version of meme coin." If an investor had put $10,000 in at the beginning of the year, their investment would now be worth over $60 million, a truly astonishing feat.

This Hong Kong-based company, previously considered a "penny stock," has only 12 employees and has generated no revenue so far in 2021. Despite a continuous decrease in R&D investment, which is projected to be only $1.07 million by 2024, the company is rumored to have received FDA approval for its chip and to be partnering with the Mayo Clinic. However, this information has yet to be found on the company's official website or in any regulatory filings.

RegenChain's product is based on a "family recipe" from traditional Chinese medicine for treating ADHD and ASD. Its clinical trials lack a control group, and the evaluation criteria lack credibility. Furthermore, the company has implemented a 38:1 stock split to lower the stock price threshold, driving the stock price up with very few shares in circulation, showcasing a sophisticated capital operation strategy. The shareholder structure shows that the company's founder and the "Taiwanese Buffett," Chen Xianzhe, collectively hold over 93% of the shares. With very low market liquidity, the stock price is highly manipulable.

Behind this surge lies the question: is it a genuine opportunity, or merely a speculative game of passing the parcel? Investors need to remain calm and rational.

The BiyaPay analyst mentioned that users can trade US stocks and Hong Kong stocks in real-time using USDT without needing to apply for an offshore account, allowing for convenient participation in global market investments while ensuring both flexibility and fund security. Instead of chasing hot trends, it is recommended to choose compliant platforms for steady progress.